Lupin launches Fluoxetine Tablets

10 Apr 2019 Evaluate

Lupin has launched Fluoxetine Tablets USP, 60mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Fluoxetine Tablets USP, 60mg, is the generic version of Alvogen Group Holdings 3 LLC’s Fluoxetine Tablets, 60mg.

It is indicated in the treatment of Major Depressive Disorder (MDD), Obsessive Compulsive Disorder (OCD), Bulimia Nervosa and panic disorder, with or without agoraphobia. Fluoxetine Tablets, 60mg, had annual sales of approximately $41 million in the US (IQVIA MAT February 2019).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2116.15 26.50 (1.27%)
17-Dec-2025 11:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.30
Dr. Reddys Lab 1276.00
Cipla 1493.60
Zydus Lifesciences 917.00
Lupin 2116.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×